Inventurus Knowledge Solutions logo

Inventurus Knowledge Solutions

IKS NSE

Key Fundamentals

SmallcapIT Enabled ServicesInformation Technology
Market Cap
₹30,132 Cr
Volatility
Moderate
P/E Ratio
39.11
EBITDA
₹1,109 Cr
Return on Equity
25.77%
Debt to Equity
0.27
Book Value
₹163.1
52W High
₹1,933
52W Low
₹1,262

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company has delivered good profit growth of 34.2% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 33.1%

Weaknesses

2
  • Stock is trading at 10.7 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

Growth Rate

Revenue Growth
18.79% lower than 3Y
Net Income Growth
48.45% higher than 3Y
Cash Flow Change
112% lower than 3Y
ROE
-5.12% lower than 3Y
ROCE
7.53% lower than 3Y
EBITDA Margin (Avg.)
15.37% higher than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 5d ago
AI opinion · based on fundamentals
Risk high

Inventurus Knowledge Solutions (IKS) is an IT services company with a market cap of ₹30,684 Cr, trading at a PE of 40.2x and 11.0x book value. The company has delivered strong profit growth of 34% CAGR over 5 years with consistent ROE above 31%, but pays no dividend and commands a premium valuation relative to its book value.

Bull Case 7
  • Strong 5-year compounded profit growth of 34% CAGR demonstrates sustained earnings momentum
  • Consistent return on equity with 3-year ROE of 33% and 5-year ROE of 36%, indicating efficient capital deployment
  • Robust 5-year compounded sales growth of 42% CAGR reflects strong revenue scaling ability
  • TTM profit growth of 41% is accelerating relative to the 3-year profit CAGR of 30%, suggesting improving profitability
  • TTM sales growth of 21% continues to show double-digit topline expansion
  • Last year ROE of 31% remains well above typical IT sector averages, showing the business continues to generate high returns on shareholder equity
  • 3-year compounded sales growth of 46% outpaces the 5-year figure of 42%, indicating the company maintained strong growth in recent years
Bear Case 7
  • Stock trades at 11.0x price-to-book value, a steep premium that leaves limited margin of safety
  • PE ratio of 40.2x is elevated and prices in significant future growth, increasing vulnerability to any earnings miss
  • Zero dividend yield despite repeated profitability suggests shareholders receive no direct income return on capital
  • TTM sales growth of 21% has decelerated sharply from the 3-year CAGR of 46%, raising questions about growth sustainability
  • Debt-to-equity ratio is not available, limiting visibility into the company's leverage and financial risk profile
  • Limited long-term track record with no 10-year data available for sales, profit, or ROE growth, making it harder to assess durability of performance
  • 52-week high and low data are unavailable, making it difficult to assess the stock's current position within its recent trading range

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 2h ago
Headwinds 2
  • No dividend declared for FY26 Aug 28

    AGM agenda confirms no dividend declared for FY26, which may disappoint income-focused investors.

  • CHRO resignation on personal grounds Sep 4

    Outgoing CHRO Manisha Kadagathur resigned due to personal reasons, creating a leadership transition in HR.

Positives 2
  • ESOP pool expansion proposed Aug 28

    AGM agenda includes ESOP pool expansion, signaling intent to attract and retain talent through equity incentives.

  • First BRSR report filed Aug 28

    IKS Health filed its first Business Responsibility and Sustainability Report for FY26, improving ESG transparency and compliance posture.

Neutral 2
  • New CHRO appointed Sep 5 Sep 4

    Amaris McComas appointed as new Chief Human Resources Officer effective September 5, 2026, succeeding Manisha Kadagathur.

  • 20th AGM set for Sep 21 Aug 18

    Inventurus Knowledge Solutions will hold its 20th AGM on September 21, 2026 via video conferencing, with director appointments on the agenda.

TL;DR: IKS Health had a quiet newsflow period dominated by routine corporate governance actions — AGM scheduling, BRSR filing, and a leadership change in HR. The ESOP expansion signals confidence in growth and talent retention, but the absence of a dividend for FY26 and the CHRO exit are minor negatives. No material business or sector-level catalysts emerged. The trend is steady with no clear directional shift; investors should watch AGM outcomes on Sep 21 for forward signals.

Quarterly Results

Particulars Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
567
620
640
643
657
724
740
781
815
858
894
Expenses
405
494
467
454
476
498
502
511
536
563
604
Operating Profit
162
126
173
189
181
226
238
270
279
295
290
OPM %
29%
20%
27%
29%
28%
31%
32%
35%
34%
34%
32%
Other Income
6
15
4
5
27
3
3
4
6
5
6
Interest
26
32
26
22
21
21
18
16
23
13
10
Depreciation
19
27
28
28
28
28
28
30
32
34
34
PBT
124
81
122
144
160
180
195
228
229
253
251
Tax %
18%
21%
22%
21%
19%
18%
22%
21%
20%
19%
23%
Net Profit
102
64
95
113
130
148
152
181
183
206
194
EPS in Rs
5.94
3.72
5.57
6.59
7.56
8.61
8.83
10.53
10.68
12
11.29
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
529
553
764
1,031
1,818
2,664
3,194
3,347
Expenses
367
348
466
639
1,297
1,893
2,110
2,213
Operating Profit
162
205
298
392
521
771
1,084
1,134
OPM %
31%
37%
39%
38%
29%
29%
34%
34%
Other Income
31
16
1
-2
40
39
17
20
Interest
7
8
7
6
61
91
72
62
Depreciation
40
30
23
25
59
113
124
131
PBT
145
183
269
359
442
606
905
961
Tax %
5%
9%
13%
15%
16%
20%
20%
—
Net Profit
137
165
233
305
370
486
722
764
EPS in Rs
167
200
13.61
17.86
21.68
28.33
42.03
44.5
Div. Payout %
0%
12%
393%
55%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
8
8
17
17
17
17
17
Reserves
275
449
630
812
1,141
1,773
2,783
Borrowings
0
76
65
52
1,311
856
753
Other Liabilities
151
53
75
107
411
274
605
Total Liabilities
434
586
788
988
2,880
2,919
4,158
Fixed Assets
36
87
76
59
1,833
1,790
1,942
CWIP
0
0
0
0
3
13
6
Investments
1
14
16
32
195
114
377
Other Assets
397
485
695
898
849
1,003
1,832
Total Assets
434
586
788
988
2,880
2,919
4,158
Figures in ₹ Crores

Cash Flow

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
163
175
233
288
210
318
674
Investing
-79
-167
-82
-158
-1,137
241
-222
Financing
-41
-37
-59
-152
780
-389
-412
Net Cash Flow
43
-28
92
-22
-147
170
39
Free Cash Flow
152
168
222
280
177
276
614
CFO/OP
118
100
93
93
58
56
80
Figures in ₹ Crores

Ratios

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
51
49
46
57
73
73
65
Cash Conversion Cycle
51
49
46
57
73
73
65
Working Capital Days
20
41
15
21
-75
10
-31
ROCE %
—
47%
47%
50%
30%
27%
32%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Inventurus Knowledge Solutions insights

59 extracted metrics + investor summaries across FY16–FY27.

Log in — free

Shareholding Pattern

DIIs7.50%Promot.63.72%FIIs8.00%Public9.98%Others10.80%As ofJun 2026

Documents

Frequently Asked Questions about Inventurus Knowledge Solutions

What does Inventurus Knowledge Solutions Ltd do?
Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform[1]
Where is Inventurus Knowledge Solutions Ltd (IKS) listed?
Inventurus Knowledge Solutions Ltd trades as IKS on the NSE and under code 544309 on the BSE.
Which sector does Inventurus Knowledge Solutions Ltd belong to?
Inventurus Knowledge Solutions Ltd is classified under the Information Technology sector, in the IT Enabled Services industry.
What is the market capitalisation of Inventurus Knowledge Solutions Ltd?
Inventurus Knowledge Solutions Ltd has a market capitalisation of ₹30,132 Cr, which places it in the Large Cap band.
What is the PE ratio of Inventurus Knowledge Solutions Ltd?
Inventurus Knowledge Solutions Ltd trades at a PE ratio of 39.11, against a book value of ₹163.1 per share.
What is the 52-week high and low of Inventurus Knowledge Solutions Ltd?
Over the last 52 weeks Inventurus Knowledge Solutions Ltd has traded between ₹1,262 and ₹1,933.
What is the Return on Equity (ROE) of Inventurus Knowledge Solutions Ltd?
Inventurus Knowledge Solutions Ltd reported a return on equity of 25.77%. Its debt-to-equity ratio is 0.27.

Company Information

Incorporated in 2006, Inventurus Knowledge Solutions Ltd provides healthcare solutions through its care enablement platform[1]

Website ikshealth.com
CEO Mr. Sachin K. Gupta
Employees 7,530
Listed 2024-12-19
Face Value ₹ 1
Issued Size 17,15,73,159

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/IKS.md for Inventurus Knowledge Solutions Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Information Technology → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List